2nd Applied Biocatalysis Summit

Memo

Understand the most recent developments in enzyme-catalyzed processes, computational technologies, and cutting-edge methodologies in biocatalytic cascade reactions to help the API and chemical industries apply biocatalysis more effectively. Specifically designed alongside experts in the fied, this conference will delve into the key technology, enzyme design, manufacturing, and scale-up challenges that must be overcome to achieve the commercial promise of biocatalysis. Join us online for 2 days of insighful content, live Q&As, and 2+ hours of networking, as we bring together medication developers, chemical manufacturers, agriculturists, and researchers working on the complex and difficult development of biocatalyst technology. Date and Time: On Wednesday November 03, 2021 at 8:50 am (ends Thursday November 04, 2021 at 4:00 pm) Prices: Conference Only - Industry pricing: USD 1699.00,Conference Only - Discounted pricing: USD 1399.00,Conference Only - Vendor pricing: USD 2548.00 URLs: Tickets: https://go.evvnt.com/855547-2?pid=5569 Brochure: https://go.evvnt.com/855547-3?pid=5569 Speakers: Adrian Ortiz Principal Scientist Amgen Inc., Andreas Bommarius Professor Georgia Tech Research Institute, Andreas Liese President and Coordinator, Head of Special Research Area Integrated Biotechnology and Process Engineering Hamburg University of Technology, Beate Mueller-Tiemann Vice President - iCMC New Products Program and Pharmaceutics Development Platform Sanofi, Bettina Bommarius Professor Georgia School of Chemical and Biomolecular Engineering, Chihui An Senior scientist Merck and Co, David H Thompson Professor - Organic Chemistry Purdue University, Deeptak Verma Senior Scientist Merck, Doug Fuerst Director - Technology Development and Synthetic Biochemistry Leader GlaxoSmithKline, Francesco Falcioni R&D leader in applied biocatalysis AstraZeneca, Jacob Forstater Senior Scientist Merck and Co, Jean Christophe Lec Research and Development Scientist Arkema, Jennifer Littlechild Professor - Biological Chemistry and Director - Exeter Biocatalysis Centre Biological Chemistry University of Exeter, Kumiko Yamamoto Scientist Amgen Inc., Mary Andorfer Postdoctoral Researcher Massachusetts Institute of Technology, Paul Race Professor - Biological Chemistry University of Bristol, Ryan Phelan Senior Scientist - Biocatalysis, Process Chem and Catalysis Group AbbVie, Sherif Elshahawi Assistant Professor Chapman University, Thierry Schlama Team Leader - Biocatalysis and Protein Engineering and Global Scientific Partnering Network Leader and Biocatalysis Platform Leader Novartis, Wai Ling Senior Scientist Merck